Amgen and Astra hope to carve out a place in asthma

Amgen and Astra hope to carve out a place in asthma

Source: 
EP Vantage
snippet: 

Pivotal data are expected soon on tezepelumab, Amgen and Astrazeneca's shot at non-eosinophilic asthma.